Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 377

Results For "CTO"

4858 News Found

PhableCare raises Rs 187 crore in Series B funding
Startup | April 12, 2022

PhableCare raises Rs 187 crore in Series B funding

The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round


Pharmapack Europe 2022 to open on May 18-19 in Paris
Packaging | April 12, 2022

Pharmapack Europe 2022 to open on May 18-19 in Paris

Pharmapack trends are a key barometer of global device and packing opportunities in 2022


Thermo Fisher Scientific deploys cryo-transmission electron microscope at CCMB, Hyderabad
Medical Device | April 12, 2022

Thermo Fisher Scientific deploys cryo-transmission electron microscope at CCMB, Hyderabad

It supports advanced research and helps scientists accelerate potential cures, drug discoveries and diagnostics research


Healthcare Venture’s Wavemaker360 appoints Monica Jain as new partner
People | April 12, 2022

Healthcare Venture’s Wavemaker360 appoints Monica Jain as new partner

Cedars-Sinai Medical Center Surgeon and Surgical Innovation Officer Dr. Jain joins the venture fund to bring clinical expertise to a portfolio of budding seed-stage healthcare companies


ReiThera and Exothera collaborate to develop large-scale, low cost per dose vaccine
Biotech | April 12, 2022

ReiThera and Exothera collaborate to develop large-scale, low cost per dose vaccine

Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation


Cambrex completes large-scale US API expansion
Biotech | April 12, 2022

Cambrex completes large-scale US API expansion

The expansion positions Cambrex with the largest and most advanced API facility in the United States


Amyris commissions industry-leading fermentation plant
Biotech | April 11, 2022

Amyris commissions industry-leading fermentation plant

The site consists of five fermentation "mini-factories" capable of concurrently producing our more than 13 currently scaled and future bio-fermented products


Glenmark Specialty receives DCGI approval for Phase 1 clinical trial of its novel molecule
Biotech | April 11, 2022

Glenmark Specialty receives DCGI approval for Phase 1 clinical trial of its novel molecule

GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology


Telix Pharmaceuticals announces licence agreement with Lilly for olaratumab
Biotech | April 11, 2022

Telix Pharmaceuticals announces licence agreement with Lilly for olaratumab

Lilly may be eligible for up to US $ 225m in payments based upon the achievement of pre-specified development, regulatory and commercial milestones


CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long Covid
Biotech | April 11, 2022

CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long Covid

These distinct gut microbial signatures can be used to predict the risk of developing long Covid and diagnose long Covid in patients with persistent symptoms after the acute infection